Clinical Trial Update: Pharmacokinetics of Caspofungin in Burn Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 pharmacokinetic study of caspofungin in burn patients has completed, reporting PK data in thermal injury patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injuries
• Thermal Injury

Drugs mentioned

• Caspofungin (caspofungin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Thermal Injury | Phase 2, Phase 3 | Status: COMPLETED